Hye-Jin Boo

Hye-Jin Boo

Auto-generated profile, based on publicly available information

Hye-Jin Boo

Department of Histology, Jeju National University College of Medicine, Jeju 63243, Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HJHyun-Ji Jang
Hyun-Ji Jang
HMHye-Young Min
Hye-Young Min
YKYun Pyo Kang
Yun Pyo Kang
HBHye-Jin Boo
Hye-Jin Boo
JKJisung Kim
Jisung Kim
HLHo-Young Lee
Ho-Young Lee
Tobacco smoking (TS) is implicated in lung cancer (LC) progression through the development of metabolic syndrome. However, direct evidence linking metabolic syndrome to TS-mediated LC progression remains to be established. Our findings demonstrate that 4-(methylnitrosamino)−1-(3-pyridyl)−1-butanone and benzo[a]pyrene (NNK and BaP; NB), components of tobacco smoke, induce metabolic syndrome characteristics, particularly hyperglycemia, promoting lung cancer progression in male C57BL/6 J mice. NB enhances glucose uptake in tumor-associated macrophages by increasing the expression and surface localization of glucose transporter (GLUT) 1 and 3, thereby leading to transcriptional upregulation of insulin-like growth factor 2 (IGF2), which subsequently activates insulin receptor (IR) in LC cells in a paracrine manner, promoting its nuclear import. Nuclear IR binds to nucleophosmin (NPM1), resulting in IR/NPM1-mediated activation of the CD274 promoter and expression of programmed death ligand-1 (PD-L1). Restricting glycolysis, depleting macrophages, or blocking PD-L1 inhibits NB-mediated LC progression. Analysis of patient tissues and public databases reveals elevated levels of IGF2 and GLUT1 in tumor-associated macrophages, as well as tumoral PD-L1 and phosphorylated insulin-like growth factor 1 receptor/insulin receptor (pIGF-1R/IR) expression, suggesting potential poor prognostic biomarkers for LC patients. Our data indicate that paracrine IGF2/IR/NPM1/PD-L1 signaling, facilitated by NB-induced dysregulation of glucose levels and metabolic reprogramming of macrophages, contributes to TS-mediated LC progression.

27 March 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
HBHye-Jin Boo
Hye-Jin Boo
HMHye-Young Min
Hye-Young Min
CPChoon-Sik Park
Choon-Sik Park
JPJong-Sook Park
Jong-Sook Park
JJJi Yun Jeong
Ji Yun Jeong
HLHo-Young Lee
Ho-Young Lee
Pulmonary emphysema is a destructive inflammatory disease primarily caused by cigarette smoking (CS). Recovery from CS-induced injury requires proper stem cell (SC) activities with a tightly controlled balance of proliferation and differentiation. Here we show that acute alveolar injury induced by two representative tobacco carcinogens, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene (N/B), increased IGF2 expression in alveolar type 2 (AT2) cells to promote their SC function and facilitate alveolar regeneration. Autocrine IGF2 signaling upregulated Wnt genes, particularly Wnt3, to stimulate AT2 proliferation and alveolar barrier regeneration after N/B-induced acute injury. In contrast, repetitive N/B exposure provoked sustained IGF2-Wnt signaling through DNMT3A-mediated epigenetic control of IGF2 expression, causing a proliferation/differentiation imbalance in AT2s and development of emphysema and cancer. Hypermethylation of the IGF2 promoter and overexpression of DNMT3A, IGF2, and the Wnt target gene AXIN2 were seen in the lungs of patients with CS-associated emphysema and cancer. Pharmacologic or genetic approaches targeting IGF2-Wnt signaling or DNMT prevented the development of N/B-induced pulmonary diseases. These findings support dual roles of AT2 cells, which can either stimulate alveolar repair or promote emphysema and cancer depending on IGF2 expression levels. Significance: IGF2-Wnt signaling plays a key role in AT2-mediated alveolar repair after cigarette smoking–induced injury but also drives pathogenesis of pulmonary emphysema and cancer when hyperactivated.

30 June 2023 in Development & Reproduction
Verified
Journal Article
Open access
PDF file
DPDeokbae Park
Deokbae Park
SLSookyoung Lee
Sookyoung Lee
HBHyejin Boo
Hyejin Boo
Hepatocellular carcinoma (HCC) is one of the most common cancers and the fourth leading cause of cancer-associated death (Bray et al., 2018). HCC rapidly progresses, and it is diagonized mostly at advanced stages. Thus, there are very few options for the prognosis and treatment of HCC. It has been suggested that metabolic reprogramming is a unique feature of cancer cells, including HCC. Aerobic glycolysis, known as the Warburg effect, is one of the metabolic reprogramming processes in cancer cells (Ward & Thompson, 2012). Under aerobic glycolysis conditions, cancer cells acquire an excessive amount of glucose to overcome their lower efficiency in producing enough energy molecules (ATP) for the proliferation and survival of cancer cells. Thus, the use of glycolysis-blocking agent, such as 2-deoxyglucose (2-DG) has been tested in some cancer cells but has been unsuccessful due to its toxicity and insufficient suppression of cancer cell growth at tolerable doses (Raez et al., 2013). HCC cells are different from normal hepatocytes in glucose metabolism and express different metabolic enzymes (Hay, 2016). Among several metabolic enzymes, hexokinase-2 (HK-2) is predominantly expressed in HCC cells. Because HK-2 is not expressed in normal hepatocytes but exclusively expressed in HCC cells, selective blockade of HK-2 can be a clinical target for the prevention or treatment of HCC. A recent study demonstrated that HK-2 depletion successfully inhibits HCC incidence in a mouse model (DeWaal et al., 2018).

31 December 2024 in Development & Reproduction
Verified
Journal Article
Open access
PDF file
DPDeokbae Park
Deokbae Park
HBHyejin Boo
Hyejin Boo
The liver is one of the critical organs for maintaining the homeostasis and health of the whole human body by controlling overall energy metabolism and detoxification. At the same time, the incidence of hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death (Bray et al., 2018). Normal, healthy hepatocytes play a key role in maintaining normal blood glucose levels by stimulating gluconeogenesis when diet-derived glucose supply is insufficient. They also uptake the excess glucose from the blood plasma and then transform it into triglyceride (TG) by stimulating hepatic de novo lipogenesis (DNL). However, such a metabolic balance was lost in many cancer cells by the well-known metabolic reprogramming, aerobic glycolysis known as the Warburg effect (Ward & Thompson, 2012). The ‘aerobic glycolysis’ shown in many cancer cells means that an excessive amount of glucose should be supplied to overcome the lower energy efficiency of cancer cells. Thus, the inhibition of aerobic glycolysis is one interesting metabolic target for suppressing the proliferation of cancer cells. Although several agents to block some steps of glycolysis have been tested, they have been unsuccessful because of unexpected toxicity and inefficient suppression of cancer cell proliferation (Raez et al., 2013).

16 September 2024
Verified
Other
Open access
HBHye-Jin Boo
Hye-Jin Boo
HMHye-Young Min
Hye-Young Min
CPChoon-Sik Park
Choon-Sik Park
JPJong-Sook Park
Jong-Sook Park
JJJi Yun Jeong
Ji Yun Jeong
HLHo-Young Lee
Ho-Young Lee
Pulmonary emphysema is a destructive inflammatory disease primarily caused by cigarette smoking (CS). Recovery from CS-induced injury requires proper stem cell (SC) activities with a tightly controlled balance of proliferation and differentiation. Here we show that acute alveolar injury induced by two representative tobacco carcinogens, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene (N/B), increased IGF2 expression in alveolar type 2 cells (AT2s) to promote their SC function and facilitate alveolar regeneration. Autocrine IGF2 signaling upregulated Wnt genes, particularly Wnt3, to stimulate AT2 proliferation and alveolar barrier regeneration after N/B-induced acute injury. In contrast, repetitive N/B exposure provoked sustained IGF2-Wnt signaling through DNMT3A-mediated epigenetic control of IGF2 expression, causing a proliferation/differentiation imbalance in AT2s and development of emphysema and cancer. Hypermethylation of the IGF2 promoter and overexpression of DNMT3A, IGF2, and the Wnt target gene AXIN2 were seen in the lungs of patients with CS-associated emphysema and cancer. Pharmacological or genetic approaches targeting IGF2-Wnt signaling or DNMT prevented the development of N/B-induced pulmonary diseases. These findings support dual roles of AT2 cells, which can either stimulate alveolar repair or promote emphysema and cancer depending on IGF2 expression levels.